Environmental exposure and cancer prevention in the Czech Republic
Authors:
E. J. Price
Authors‘ workplace:
RECETOX, PřF MU, Brno
Published in:
Klin Onkol 2026; 39(Supplementum 1): 46-48
Category:
Review
doi:
https://doi.org/10.48095/ccko2026S46
Overview
Cancer risk is predominantly shaped by environmental exposures interacting with genetic susceptibility, yet modifiable non-genetic determinants remain insufficiently characterised. The human exposome framework promotes a comprehensive, life-course approach to studying chemical, biological, and physical exposures alongside socioeconomic and psychosocial factors, but it is underutilised in cancer research. Systematically mapping biomarkers of exposure to each hallmark of cancer could provide a powerful strategy to identify modifiable risk factors with translational relevance. Czechia, with its pronounced geographic variation in cancer incidence and strong research infrastructure, provides an ideal setting to pioneer such “functional exposomics” approaches. Integrating these methods into cancer research could help identify actionable environmental drivers and generate mechanistic insights to advance precision cancer prevention.
Keywords:
human exposome – precision prevention – modifiable environmental exposures
Sources
1. Lichtenstein P, Holm NV, Verkasalo PK et al. Environmental and heritable factors in the causation of cancer – analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 2000; 343 (2): 78–85. doi: 10.1056/nejm200007133430201.
2. Mucci LA, Hjelmborg JB, Harris JR et al. Familial risk and heritability of cancer among twins in Nordic countries. JAMA 2016; 315 (1): 68. doi: 10.1001/jama.2015.17703.
3. Schafer EJ, Laversanne M, Sung H et al. Recent patterns and trends in global prostate cancer incidence and mortality: an update. Eur Urol 2025; 87 (3): 302–313. doi: 10.1016/j.eururo.2024.11.013.
4. Wild CP. Complementing the genome with an “exposome”: the outstanding challenge of environmental exposure measurement in molecular epidemiology. Cancer Epidemiol Biomarkers Prev 2005; 14 (8): 1847–1850. doi: 10.1158/1055-9965.epi-05-0456.
5. Price EJ, Vitale CM, Miller GW et al. Merging the exposome into an integrated framework for “omics” sciences. iScience 2022; 25 (3): 103976. doi: 10.1016/j.isci.2022.103976.
6. Foreman AL, Warth B, Hessel EV et al. Adopting mechanistic molecular biology approaches in exposome research for causal understanding. Environ Sci Technol 2024; 58 (17): 7256–7269. doi: 10.1021/acs.est.3c07961.
7. Young AS, Mullins CE, Sehgal N et al. The need for a cancer exposome atlas: a scoping review. JNCI Cancer Spectrum 2025; 9 (1): pkae122. doi: 10.1093/jncics/pkae122.
8. Wild CP. Environmental exposure measurement in cancer epidemiology. Mutagenesis 2008; 24 (2): 117–125. doi: 10.1093/mutage/gen061.
9. Laman Trip DS, Aarts E, Magnusson G et al. Unifying the genetic landscape of common and rare diseases via latent neighborhoods. bioRxiv 2026. doi: 10.64898/2026.01.27.701945. [online]. Available from: https: //www.biorxiv.org/content/10.64898/2026.01.27.701945v1.
10. Hanahan D. Hallmarks of cancer-Then and now, and beyond. Cell 2026; 189 (8): 2254–2277. doi: 10.1016/j.cell.2025.12.049.
11. López-Otín C, Kroemer G. Hallmarks of health. Cell 2021; 184 (7): 1929–1939. doi: 10.1016/j.cell.2021.03.033.
12. Peters A, Nawrot TS, Baccarelli AA. Hallmarks of environmental insults. Cell 2021; 184 (6): 1455–1468. doi: 10.1016/j.cell.2021.01.043.
13. Pehalova L, Krejci D, Snajdrova L et al. Cancer incidence trends in the Czech Republic. Cancer Epidemiol 2021; 74 : 101975. doi: 10.1016/j.canep.2021.101975.
14. OECD, European Commission. EU Country Cancer Profile: Czechia 2025. [online]. Available from: https: //www.oecd.org/en/publications/eu-country-cancer-profile-czechia-2025_c23a8f29-en.html.
15. SZÚ. Environmental health monitoring system. [online]. Available from: https: //szu.gov.cz/en/publications-data/environmental-health/.
16. Ministry of Health of the Czech Republic. Czech national cancer control plan 2030 (2022). [online]. Available from: https: //mzd.gov.cz/wp-content/uploads/2022/07/2207_MZCR_NOPL_CR_2030_EN_v03.pdf.
Labels
Paediatric clinical oncology Surgery Clinical oncologyArticle was published in
Clinical Oncology
2026 Issue Supplementum 1
-
All articles in this issue
- Editorial
- Cancer screening programmes in the Czech Republic and their results
- Polygenic risk score and its role in cancer susceptibility
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- Physical activity in cancer prevention
- Nicotine products on the market and cancer risk
- Impact of obesity on the development of malignant tumors – metabolic syndrome
- Mental health and sleep in cancer prevention – removing barriers to health
- Environmental exposure and cancer prevention in the Czech Republic
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Disruption of hormonal balance and the potential development of cancer – the impact of endocrine disruptors
- Microplastic in human body – a critical insight into current microplastic research
- Microbiome in early cancer detection – biomarker potential and limitations
- Probiotics, postbiotics, and synbiotics in the prevention of oncological diseases
- Clinical Oncology
- Journal archive
- Current issue
- Online only
- About the journal
Most read in this issue
- Multicancer early detection (MCED) tests – an overview of technologies and clinical evidence
- OncoVis: carcinogenic substances, their classification and potential impact on cancer development – an interactive dashboard for clinical practice
- Cancer screening programmes in the Czech Republic and their results
- Editorial